To include your compound in the COVID-19 Resource Center, submit it here.

Atu027: Updated Phase I data

Updated data from an ongoing, open-label, dose-escalation Phase I trial in 24 evaluable

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE